Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Oncolytics Biotech Inc announces a meeting focused on its single-arm pivotal study of candidate drug Pelareorep in second-line and later metastatic colorectal adenocarcinoma (SCAC) patients

Oncolytics Biotech Inc announces a meeting focused on its single-arm pivotal study of candidate drug Pelareorep in second-line and later metastatic colorectal adenocarcinoma (SCAC) patients

老虎证券老虎证券2026/04/06 13:09
Show original
The study aims to evaluate the efficacy and safety of Pelareorep in this group of refractory patients.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!